Company: INMB
Filing Date: 2025-04-09
Form Type: 8-K
Source: 0001213900-25-030129
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-04-09
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial statements and Exhibits

(d) Exhibits.

  99.1      Poster Presentation                                                          
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           INMUNE BIO INC.                               
  Date: April 9, 2025      By:                  /s/ David Moss           
                           Name:                David Moss               
                           Title:               Chief Financial Officer